7 April 2026 - The MHRA-led Access Consortium 2026 action plan will deepen collaboration, streamline work sharing, and speed up access to safe, high-quality medicines for patients across member countries.

The heads of the regulatory authorities from Australia, Canada, Singapore, Switzerland and the UK agreed priorities to strengthen collaboration and improve regulatory efficiency at the first Access Consortium meeting of 2026 on 30 March 2026, chaired for the first time by MHRA.

An action plan for 2026 was endorsed to support the GROWTH manifesto agreed previously, with particular focus on enhancing work sharing processes.

Read UK Government press release